ETC
CLLS

Exchange Traded Concepts’s Cellectis CLLS Stock Holding History

Exchange Traded Concepts’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-347,174
Closed -$2.82M – 1229
2021
Q4 		$2.82M Buy
347,174
+111,591
+47% +$1.1M 0.05% 207
2021
Q3 		$2.97M Buy
235,583
+13,502
+6% +$187K 0.08% 186
2021
Q2 		$3.44M Buy
222,081
+59,738
+37% +$1M 0.11% 145
2021
Q1 		$3.28M Buy
162,343
+103,279
+175% +$2.55M 0.12% 114
2020
Q4 		$1.6M Buy
59,064
+17,667
+43% +$396K 0.07% 181
2020
Q3 		$766K Buy
41,397
+18,445
+80% +$327K 0.04% 194
2020
Q2 		$409K Buy
+22,952
New +$349K 0.07% 241

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Exchange Traded Concepts's CLLS Position: Q1 2022 in Review

Exchange Traded Concepts sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 347,174 shares — an estimated $2.82M sold.

Exchange Traded Concepts first reported a position in CLLS in Q2 2020 and held it in 7 quarters. The position peaked at $3.44M in Q2 2021. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.

  • Exchange Traded Concepts reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
  • Exchange Traded Concepts sold 347,174 Cellectis shares in Q1 2022, an estimated $2.82M.
  • Exchange Traded Concepts first reported a position in Cellectis in Q2 2020 and held it in 7 quarters.
  • Exchange Traded Concepts's Cellectis position peaked at $3.44M in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.

Based on Exchange Traded Concepts's 13F filing for Q1 2022, filed 26 Apr 2022.